Atlas Trials

Ceftriaxone Dosage for Non-Critical Community-Acquired Pneumonia

Clinical trial NCT07537413 · NOT_YET_RECRUITING

Trial details

NCT number
NCT07537413
Sponsor
University of Maryland, Baltimore
Status
NOT_YET_RECRUITING
Phase
Phase 4
Study type
INTERVENTIONAL
Community Acquired Pneumonia (CAP)
Start date
2026-09-01
Primary completion
2027-08-31
Enrollment
430

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.